Position in AMGN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$9,210,884
+$5,898,217 QoQ
Shares Held
25,436
+170.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#580
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MISSION WEALTH MANAGEMENT, LP holds $105,799,986 across 14 Drug Manufacturers - General names. AMGN ranks #5 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
25,625 | $30,735,396 | |
| 2 | JNJ |
Johnson & Johnson
|
96,816 | $24,588,359 | |
| 3 | ABBV |
AbbVie Inc.
|
69,052 | $17,376,245 | |
| 4 | MRK |
Merck & Co., Inc.
|
72,281 | $9,288,108 | |
| 5 | AMGN |
Amgen Inc
This page
|
25,436 | $9,210,884 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
59,419 | $3,423,722 | |
| 7 | NVS |
Novartis AG
|
19,690 | $3,085,816 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
16,879 | $2,132,492 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,210,884 | 25,436 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $3,312,667 | 9,415 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,379,803 | 10,326 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,988,215 | 10,589 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $3,174,617 | 11,370 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $3,424,246 | 10,991 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $2,727,076 | 10,463 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,982,193 | 12,359 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $3,707,531 | 11,866 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $3,599,775 | 12,661 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $3,615,515 | 12,553 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $3,099,071 | 11,531 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $2,647,588 | 11,925 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $2,918,647 | 12,073 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $3,092,848 | 11,776 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $2,621,402 | 11,630 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $3,057,307 | 12,566 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $2,517,346 | 10,410 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $2,426,076 | 10,784 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,420,169 | 11,381 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $2,591,550 | 10,632 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,592,102 | 10,418 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,590,816 | 6,919 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,947,628 | 7,663 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $1,626,254 | 6,895 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $1,376,131 | 6,788 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||